Dr. Reddy's Laboratories Limited (RDY Quick QuoteRDY - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 15.9% in the past one-month time frame.

The company has not seen any estimate revisions in the past one month, while the Zacks Consensus Estimate for the current quarter hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Dr. Reddy's Laboratories currently has a Zacks Rank #4 (Sell).

A better-ranked stock in the Medical sector is Alexion Pharmaceuticals, Inc. , which currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is RDY going up? Or down? Predict to see what others think: Up or Down

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure.

See these buy recommendations now >>